Key result
Meeting 1997 ACR criteria shows no difference in 10-year damage or death versus 2012 SLICC criteria.
Why the study?
The impact of fulfilling the 1997 ACR versus only the 2012 SLICC classification criteria on damage and mortality in SLE patients over 10 years was unclear.
Does meeting ACR criteria compared to SLICC criteria alone influence damage accrual or mortality in SLE patients?
Cohort (n=192)
No
Does meeting ACR criteria compared to SLICC criteria alone influence damage accrual or mortality in SLE patients?
Hazard Ratio: 0.991 (95% CI 0.453–2.167)
SLE classification status at inception identifies different clinical phenotypes but does not influence 10-year damage accrual or mortality.
Comparable 10-year damage and mortality risks in SLICC-only versus ACR-classified SLE; leaves open whether criteria status predicts outcomes.
Objective To compare damage and mortality, from inception up to 10-year follow-up, between SLE patients meeting at baseline the 1997 ACR criteria or only the 2012 SLICC classification criteria. Methods Patients fulfilling the ACR and/or the SLICC classification criteria for SLE were enrolled at inception and followed-up to 10 years at an academic lupus clinic. Damage was defined as SLICC Damage Index (SDI) score ≥1. We assessed with multivariate Cox models the damage and mortality outcomes, according to SLE classification status at inception, adjusting for potential baseline confounders. Results We recruited 192 patients (69.8% fulfilling at inception the ACR criteria and 30.2% only the SLICC criteria). During follow-up, 24.0% of patients accrued organ damage and 4.2% died. Patients meeting ACR criteria compared to those with SLICC criteria alone presented during follow-up with more cases of lupus nephritis (35.1% versus 13.8%, p < 0.01), but less thrombotic antiphospholipid syndrome (4.5% versus 17.2%, p < 0.01). The Cox models showed no significant differences in risk for damage [hazard ratio (HR) (95% CI) 0.991 (0.453-2.167)] or death [hazard ratio (HR) (95% CI) 0.694 (0.107-4.506)] between groups. Conclusion The SLE classification status at inception identified different patterns of clinical phenotype, but did not influence damage accrual or mortality up to 10-year follow-up.
No takes yet. Share an insight, caveat, or question.
Inês et al. (2017) conducted a cohort in Systemic Lupus Erythematosus (SLE) (n=192). Meeting the 1997 ACR criteria vs. Meeting only the 2012 SLICC classification criteria was evaluated on Risk for damage (SLICC Damage Index score ≥1) (HR 0.991, 95% CI 0.453-2.167). Meeting the 1997 ACR criteria compared to only the 2012 SLICC criteria at inception did not significantly influence the risk of damage (HR 0.991; 95% CI 0.453-2.167) or death up to 10-year follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: